FDA Enforcement Class II Ongoing

UFSK Treatment chair 500 XLE- Treatment chair for positioning and support of the patient during diagnostic and therapeutic treatments of temporary to short-term duration, especially in ophthalmology Art.no. / REF no.: 15000004 Art.no. / REF no.: 15000006

Recall: Z-2212-2023 · Reported July 26, 2023

Enforcement

Recall Number
Z-2212-2023
Event ID
92534
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
UFSK - International OSYS Gmbh
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
July 26, 2023
Initiation Date
May 31, 2023
Classification Date
July 20, 2023
Address
Kirchhoffstr. 1, N/A, Ratisbon, N/A, N/A, Germany

Description

UFSK Treatment chair 500 XLE- Treatment chair for positioning and support of the patient during diagnostic and therapeutic treatments of temporary to short-term duration, especially in ophthalmology Art.no. / REF no.: 15000004 Art.no. / REF no.: 15000006

Reason

Service life of the electrical seat part drive of the treatment chair may be shortened unexpectedly after several years of use due to a potential wear-related reduction in the self-locking of the drive and may remain undetected. A worsened self-locking of the seat drive can lead to overriding the drive s end position when positioning the patient with the seat part in an inclined position

Code Info

Art.no. / REF no.: 15000004 Serial number range: 2000- 2999 Art.no. / REF no.: 15000006 Serial number range: 3000-4506

Distribution

Nationwide

Quantity

239 chairs US